CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 21,823	$ 23,897	$ 46,145	$ 45,812
General and administrative	7,212	8,277	15,216	16,784
Total operating expenses	29,035	32,174	61,361	62,596
Loss from operations	(29,035)	(32,174)	(61,361)	(62,596)
Other income:
Interest income	1,196	2,195	2,718	4,184
Total other income	1,196	2,195	2,718	4,184
Net loss	$ (27,839)	$ (29,979)	$ (58,643)	$ (58,412)
Net loss per share attributable to common stockholders, basic	$ (0.41)	$ (0.45)	$ (0.86)	$ (0.88)
Net loss per share attributable to common stockholders, diluted	$ (0.41)	$ (0.45)	$ (0.86)	$ (0.88)
Weighted-average common shares outstanding, basic	68,299,170	67,033,150	68,165,068	66,651,547
Weighted-average common shares outstanding, diluted	68,299,170	67,033,150	68,165,068	66,651,547
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale marketable securities	$ 17	$ (262)	$ 7	$ 334
Total other comprehensive income (loss)	17	(262)	7	334
Comprehensive loss	$ (27,822)	$ (30,241)	$ (58,636)	$ (58,078)